SCHEMBL10009845

SCHEMBL10009845

COc1ccc(-c2c3ccccc3c(-c3cc4c(c5ccccc35)-c3ccccc3C4(C)C)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.42
▸ ABCB1 P08183 1/20 0.42
▸ BCR P11274 1/20 0.42
▸ PGR P06401 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ PDK2 Q15119 3/20 0.40
▸ HDAC4 P56524 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ ACACA Q13085 1/20 0.38
▸ ENPP1 P22413 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ GPR84 Q9NQS5 1/20 0.36
▸ BACE1 P56817 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12952515 0.95 ABL1 (0.45) ABL1ABCB1BCRPGRACHE
SCHEMBL13150216 0.92 PDK2 (0.40) ABL1ABCB1BCRPGRACHE
SCHEMBL13026291 0.90 PGR (0.37) ABL1ABCB1BCRPGRACHE
SCHEMBL10153818 0.85 PDK2 (0.50) ABL1ABCB1BCRPGRACHE
SCHEMBL10153348 0.84 PDK2 (0.52) ABL1ABCB1BCRPGRACHE
SCHEMBL10153548 0.84 PDK2 (0.52) ABL1ABCB1BCRPGRACHE
SCHEMBL14600432 0.84 PDK2 (0.52) ABL1ABCB1BCRPGRACHE
SCHEMBL10153835 0.84 PDK2 (0.49) ABL1ABCB1BCRPGRACHE
SCHEMBL10153227 0.84 PDK2 (0.49) ABL1ABCB1BCRPGRACHE
SCHEMBL10153443 0.84 PDK2 (0.52) ABL1ABCB1BCRPGRACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Rohm and Haas Electronic Materials Korea Let. (KR) 2012-04-19 — — US disclosed
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Rohm and Haas Electronic Materials Korea Let. (KR) 2012-04-19 — — US disclosed
WO-2010114266-A2 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOW ADVANCED DISPLAY MATERIALS,LTD. (KR) 2010-10-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME OCIAD1, OCIAD2, ODC1 ABL1 3079/4885ABCB1 3003/4885BCR 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback